The program develops and translates immunotherapy modalities, such as RNA-based vaccines, adoptive cellular therapies, genetically modified T cells and microbiome-based therapy, into first-in-human studies. The Comparative Oncology Initiative has allowed IOM investigators to validate new technologies in pet dog trials while a cadre of clinical trialists move these and other UF findings into human application.…| Cancer Center
The UF Health Directory enables you to find faculty, staff and students across the UF Health system and easily update all of your professional profile information in one place.| directory.ufhealth.org